Related Experiment Video
Updated: Aug 8, 2026
Technique of Porcine Liver Procurement and Orthotopic Transplantation using an Active Porto-Caval Shunt
Published on: May 7, 2015
Transjugular intrahepatic portosystemic shunt for portal hypertension: 30 years experience from China
Yong Lv1,2, Daiming Fan3, Guohong Han4
1Department of Liver Diseases and Digestive Interventional Radiology, National Clinical Research Center for Digestive Diseases and Xijing Hospital of Digestive Diseases, Fourth Military Medical University, China.
Insights
Transjugular intrahepatic portosystemic shunt (TIPS) effectively manages severe liver disease complications in China. This review details TIPS history, current use, and complication management for portal hypertension.
Area of Science:
- Hepatology
- Interventional Radiology
- Gastroenterology
Background:
- Liver diseases pose a significant global health challenge, particularly in China where viral hepatitis affects millions.
- Portal hypertension is a severe complication of chronic liver disease, leading to conditions like ascites, hepatic encephalopathy, and variceal bleeding.
- Transjugular intrahepatic portosystemic shunt (TIPS) is a crucial intervention for managing these complications.
Purpose of the Study:
- To review the historical development of TIPS in China.
- To outline the current applications of TIPS in managing portal hypertension complications.
- To discuss the management of complications associated with TIPS procedures.
Main Methods:
- Literature review focusing on TIPS in the Chinese context.
- Analysis of historical data and current clinical practices.
- Synthesis of information on TIPS application and complication management.
Main Results:
- TIPS has been utilized in China for 30 years, with evolving techniques and applications.
- TIPS plays a vital role in managing severe complications of portal hypertension.
- Understanding and managing TIPS-related complications is essential for patient outcomes.
Conclusions:
- TIPS is an established and evolving treatment for portal hypertension complications in China.
- Continued research and clinical practice refinement are necessary for optimizing TIPS therapy.
- This review provides a comprehensive overview of TIPS in China, aiding clinical decision-making.
Abstract:
Liver diseases are a major cause of illness and death worldwide. In China, liver diseases, primarily viral hepatitis, affect approximately 300 million people, thus having a major impact on the global burden of liver diseases. Portal hypertension is the most severe complication of chronic liver diseases, including ascites, hepatic encephalopathy and bleeding from gastroesophageal varices. Transjugular intrahepatic portosystemic shunt (TIPS) represents a very effective treatment of these complications. Since its introduction 30 years ago in China, the use of TIPS has evolved and has played an increasingly important role in the management of the complications of portal hypertension. This review will focus on the history, current application and management of complications of TIPS in China.
